| Designated contracting states Tooltip | AL | Lapse: 09.05.2018 | AT | | BE | | BG | | CH | | CY | Lapse: 09.05.2018 | CZ | | DE | | DK | | EE | Lapse: 09.05.2018 | ES | | FI | | FR | | GB | | GR | | HR | | HU | | IE | | IS | Lapse: 09.09.2018 | IT | | LI | | LT | | LU | Lapse: 21.09.2018 | LV | Lapse: 09.05.2018 | MC | Lapse: 09.05.2018 | MK | Lapse: 09.05.2018 | MT | Lapse: 21.09.2018 | NL | | NO | | PL | | PT | | RO | | RS | | SE | | SI | | SK | | SM | Lapse: 09.05.2018 | TR | | Examination procedure | 27.03.2018 | Receipt of the translation of the claim(s) | Entry into regional phase | 25.03.2013 | Translation filed | | 03.04.2013 | National basic fee paid | | 03.04.2013 | Search fee paid | | 03.04.2013 | Designation fee(s) paid | | 03.04.2013 | Examination fee paid | | Fees paid | Renewal fee | 20.09.2013 | Renewal fee patent year 03 | 24.09.2014 | Renewal fee patent year 04 | 11.09.2015 | Renewal fee patent year 05 | 13.09.2016 | Renewal fee patent year 06 | 12.09.2017 | Renewal fee patent year 07 | European patent granted | 09.05.2018 | Opposition procedure | 12.02.2019 | No opposition filed within time limit | published on 17.04.2019 | INPADOC data Tooltip | The EPO does not accept any responsibility for the accuracy of legal status data relating to the post-grant phase, including but not limited to their completeness and fitness for specific purposes, nor can it guarantee that such data are up to date. For authoritative information, please refer to the relevant national patent authority. | Event date: | 31.07.2013 | | Event description: | DESIGNATED CONTRACTING STATES | Kind Code of Ref Document: | A1 | Designated State(s): | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | | Event date: | 31.07.2013 | | Event description: | REQUEST FOR EXAMINATION FILED | Effective DATE: | 20130403 | | Event date: | 31.07.2013 | | Event description: | REQUEST FOR EXTENSION OF THE EUROPEAN PATENT | Validation States: | BA ME | | Event date: | 04.03.2015 | | Event description: | INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT | IPC CLASSIFICATION: | C07D 471/04 20060101AFI20150127BHEP | | Event date: | 04.03.2015 | | Event description: | INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT | IPC CLASSIFICATION: | A61K 31/53 20060101ALI20150127BHEP | | Event date: | 04.03.2015 | | Event description: | INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT | IPC CLASSIFICATION: | A61P 31/16 20060101ALI20150127BHEP | | Event date: | 04.03.2015 | | Event description: | INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT | IPC CLASSIFICATION: | A61P 43/00 20060101ALI20150127BHEP | | Event date: | 04.03.2015 | | Event description: | SUPPLEMENTARY SEARCH REPORT DRAWN UP AND DESPATCHED | Effective DATE: | 20150202 | | Event date: | 04.03.2015 | | Event description: | INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT | IPC CLASSIFICATION: | C07D 471/14 20060101ALI20150127BHEP | | Event date: | 26.04.2017 | | Event description: | INTENTION TO GRANT ANNOUNCED | Effective DATE: | 20170329 | | Event date: | 13.09.2017 | | Event description: | INTENTION TO GRANT ANNOUNCED (DELETED) | | Event date: | 20.09.2017 | | Event description: | FIRST EXAMINATION REPORT DESPATCHED | Effective DATE: | 20170822 | | Event date: | 13.12.2017 | | Event description: | INTENTION TO GRANT ANNOUNCED | Effective DATE: | 20171117 | | Event date: | 09.05.2018 | | Event description: | DESIGNATED CONTRACTING STATES | Kind Code of Ref Document: | B1 | Designated State(s): | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | | Event date: | 09.05.2018 | | Event description: | REQUEST FOR EXTENSION OF THE EUROPEAN PATENT | Validation States: | BA ME | | Event date: | 09.05.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG GB FG4D | Code Expl.: | +EUROPEAN PATENT GRANTED | | Event date: | 15.05.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG AT REF 997491 AT T | Code Expl.: | +REFERENCE TO AT NUMBER (EP PATENT VALIDATED IN AUSTRIA) | Effective DATE: | 20180515 | | Event date: | 15.05.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG CH EP | Code Expl.: | +EUROPEAN PATENT TAKES EFFECT AS A NATIONAL PATENT IN CH/LI | | Event date: | 07.06.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG DE R096 602011048283 DE | Code Expl.: | +DPMA PUBLICATION OF MENTIONED EP PATENT GRANT | | Event date: | 30.05.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG IE FG4D | Code Expl.: | +EUROPEAN PATENTS GRANTED DESIGNATING IRELAND | | Event date: | 30.07.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG DK T3 | Code Expl.: | +EP PATENT WITH DANISH CLAIMS | Effective DATE: | 20180719 | | Event date: | 07.08.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SE TRGR | Code Expl.: | +TRANSLATION OF GRANTED EP PATENT | | Event date: | 13.08.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FR PLFP | Code Expl.: | +FEE PAYMENT | Year of Fee Payment: | 8 | | Event date: | 22.08.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG NL FP | Code Expl.: | TRANSLATION FOR EP FILED (ENTRY OF EP INTO COUNTRY) | | Event date: | 25.09.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG ES FG2A 2683153 ES T3 | Code Expl.: | +DEFINITIVE PROTECTION | Effective DATE: | 20180925 | | Event date: | 08.10.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG NO T2 | Code Expl.: | +ENTRY OF EP PATENT INTO NATIONAL PHASE OF NORWAY [PUBL. OF TRANSLATION] | Effective DATE: | 20180509 | | Event date: | 30.11.2018 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | LV | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180509 | | Event date: | 25.01.2019 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG GR EP 20180402171 GR | Code Expl.: | +EP PATENT VALIDATED IN GREECE | Effective DATE: | 20190109 | | Event date: | 31.01.2019 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | EE | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180509 | | Event date: | 28.02.2019 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | SM | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180509 | | Event date: | 28.02.2019 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HU AG4A E039859 HU | Code Expl.: | +FILING OF THE TRANSLATION OF THE TEXT OF EUROPEAN PATENTS | | Event date: | 12.02.2019 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG DE R097 602011048283 DE | Code Expl.: | +NO OPPOSITION FILED AGAINST GRANTED PATENT, OR EPO OPPOSITION PROCEEDINGS CONCLUDED WITHOUT DECISION | | Event date: | 17.04.2019 | | Event description: | NO OPPOSITION FILED | Effective DATE: | 20190212 | | Event date: | 30.04.2019 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | MC | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180509 | | Event date: | 28.06.2019 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | LU | Free Format Text: | LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES | Effective DATE: | 20180921 | | Event date: | 28.09.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG PT SC4A 2620436 PT 20180928 T | Code Expl.: | +TRANSLATION IS AVAILABLE | Free Format Text: | AVAILABILITY OF NATIONAL TRANSLATION | Effective DATE: | 20180807 | | Event date: | 07.08.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG RO EPE | Code Expl.: | +EP PATENT VALID IN ROMANIA | | Event date: | 29.11.2019 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | AL | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180509 | | Event date: | 05.10.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR T1PR P20181250 HR | Code Expl.: | +EP PATENT VALIDATED IN CROATIA | | Event date: | 23.08.2019 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20190809 | Year of Fee Payment: | 9 | | Event date: | 02.08.2018 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR TUEP P20181250 HR | Code Expl.: | REQUEST FOR EP VALIDATION RECEIVED | | Event date: | 31.01.2020 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | MT | Free Format Text: | LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES | Effective DATE: | 20180921 | | Event date: | 30.06.2020 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | MK | Free Format Text: | LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES | Effective DATE: | 20180509 | | Event date: | 30.06.2020 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | CY | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180509 | | Event date: | 31.07.2020 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG CH SPCF | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIRUM MARBOXILUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67426 21.02.2020 | Filing DATE: | 20200731 | | Event date: | 31.07.2020 | | Event description: | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | IS | Free Format Text: | LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT | Effective DATE: | 20180909 | | Event date: | 02.10.2020 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20200907 | Year of Fee Payment: | 10 | | Event date: | 26.02.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG CH SPCG | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIRUM MARBOXILUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67426 21.02.2020 | SPC Suppl Protection Certif: | C02620436/01 | Filing DATE: | 20200731 | Extension DATE: | 20350220 | | Event date: | 03.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG NL SPCF | Code Expl.: | APPLICATION FOR A SUPPLEMENTARY PROTECTION CERTIFICATE | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL, ALSMEDE FARMACEUTISCH AANVAARDBARE ZOUTEN EN SOLVATEN ERVAN; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 301093 | Filing DATE: | 20210302 | Expiry DATE: | 20310920 | Extension DATE: | 20360107 | | Event date: | 22.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG NO SPCF | Code Expl.: | FILING OF SUPPLEMENTARY PROTECTION CERTIFICATE | Free Format Text: | PRODUCT NAME: BALOKSAVIRMARBOKSIL; REG. NO/DATE: EU/1/20/1500 20210114 | SPC Suppl Protection Certif: | 2021011 | Filing DATE: | 20210308 | | Event date: | 06.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SE SPCF | Code Expl.: | APPLICATION FOR SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REG. NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 2190007-1 | | Event date: | 12.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG LT SPCF | Code Expl.: | FILING AN SPC | Free Format Text: | PRODUCT NAME: BALOKSAVIRO MARBOKSILAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/20/1500 20210107 | SPC Suppl Protection Certif: | PA2021505 | Filing DATE: | 20210319 | Expiry DATE: | 20310921 | | Event date: | 15.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG AT SPCF 997491 AT T | Code Expl.: | +FILING AN SPC | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/20/1500 (MITTEILUNG) 20210108 | SPC Suppl Protection Certif: | 7/2021 | Filing DATE: | 20210303 | Effective DATE: | 20210415 | | Event date: | 28.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HU AA1S E039859 | Code Expl.: | +INFORMATION ON APPLICATION FOR A SUPPLEMENTARY PROTECTION CERTIFICATE | SPC Suppl Protection Certif: | S2100010 | Filing DATE: | 20210323 | | Event date: | 03.05.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG DK CTFF | Code Expl.: | APPLICATION FOR SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL ELLER ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF; REG. NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | CA 2021 00004 | Filing DATE: | 20210302 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | | Event date: | 31.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG IE SPCF | Code Expl.: | REQUEST FOR GRANT OF SUPPLEMENTARY PROTECTION CERTIFICATE | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 2021/006 | Filing DATE: | 20210302 | | Event date: | 12.05.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SK SPCF | Code Expl.: | +FILING OF AN SPC | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 50005-2021 | Filing DATE: | 20210331 | | Event date: | 07.05.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG BE SPCF | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT HIERVAN; AUTHORISATION NUMBER AND DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 2021C/510 | Filing DATE: | 20210330 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | | Event date: | 12.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FI SPCF | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE APPLICATION FILED | SPC Suppl Protection Certif: | C20210005 | | Event date: | 24.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG IT SPCF 502018000023450 IT | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL O UN SUO SALE O SOLVATO FARMACEUTICAMENTE ACCETTABILE(XOFLUZA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1500, 20210108 | SPC Suppl Protection Certif: | 132021000000038 | | Event date: | 15.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FR CP | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 21C1012 | Filing DATE: | 20210315 | | Event date: | 02.06.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG ES SPCF | Code Expl.: | REQUEST FOR SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1500; DATE OF FIRST AUTHORISATION IN EEA: 20210107 | SPC Suppl Protection Certif: | C202130015 | Effective DATE: | 20210330 | | Event date: | 26.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG DE R065 602011048283 DE | Code Expl.: | +REQUEST FOR GRANT OF SUPPLEMENTARY PROTECTION CERTIFICATE VALIDLY FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL SOWIE SEINE PHARMAZEUTISCH ANNEHMBAREN SALZE UND SOLVATE; REGISTRATION NO/DATE: EU/1/20/1500 20210107 | SPC Suppl Protection Certif: | 122021000017 | Filing DATE: | 20210318 | Expiry DATE: | 20310922 | | Event date: | 21.07.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG GB CTFF | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF.; REGISTERED: UK EU/1/20/1500(FOR NI) 20210108; UK FURTHER MAS ON IPSUM 20210108 | SPC Suppl Protection Certif: | SPC/GB21/036 | Filing DATE: | 20210622 | | Event date: | 06.04.2018 | | Event description: | (EXPECTED) GRANT | Free Format Text: | ORIGINAL CODE: 0009210 | | Event date: | 30.03.2018 | | Event description: | GRANT FEE PAID | Free Format Text: | ORIGINAL CODE: EPIDOSNIGR3 | | Event date: | 16.11.2017 | | Event description: | DESPATCH OF COMMUNICATION OF INTENTION TO GRANT A PATENT | Free Format Text: | ORIGINAL CODE: EPIDOSNIGR1 | | Event date: | 09.08.2017 | | Event description: | INFORMATION RELATED TO DISAPPROVAL OF COMMUNICATION OF INTENTION TO GRANT BY THE APPLICANT OR RESUMPTION OF EXAMINATION PROCEEDINGS BY THE EPO DELETED | Free Format Text: | ORIGINAL CODE: EPIDOSDIGR1 | | Event date: | 28.03.2017 | | Event description: | DESPATCH OF COMMUNICATION OF INTENTION TO GRANT A PATENT | Free Format Text: | ORIGINAL CODE: EPIDOSNIGR1 | | Event date: | 28.06.2013 | | Event description: | PUBLIC REFERENCE MADE UNDER ARTICLE 153(3) EPC TO A PUBLISHED INTERNATIONAL APPLICATION THAT HAS ENTERED THE EUROPEAN PHASE | Free Format Text: | ORIGINAL CODE: 0009012 | | Event date: | 15.03.2019 | | Event description: | INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT | Free Format Text: | STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT | | Event date: | 04.10.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG DK CTFG | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) ISSUED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL ELLER ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF; REG. NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | CR 2021 00004 | Filing DATE: | 20210302 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | | Event date: | 13.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG IT SPCG 502018000023450 IT | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL O UN SUO SALE O SOLVATO FARMACEUTICAMENTE ACCETTABILE(XOFLUZA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1500, 20210108 | SPC Suppl Protection Certif: | 132021000000038 | Extension DATE: | 20360108 | | Event date: | 01.10.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20210914 | Year of Fee Payment: | 11 | | Event date: | 25.01.2022 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG ES SPCG | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1500; DATE OF FIRST AUTHORISATION IN EEA: 20210107 | SPC Suppl Protection Certif: | C202130015 | Extension DATE: | 20360108 | Effective DATE: | 20220119 | | Event date: | 15.03.2019 | | Event description: | NO OPPOSITION FILED WITHIN TIME LIMIT | Free Format Text: | ORIGINAL CODE: 0009261 | | Event date: | 15.04.2022 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG AT UEP 997491 AT T | Code Expl.: | +PUBLICATION OF TRANSLATION OF EUROPEAN PATENT SPECIFICATION | Effective DATE: | 20180509 | | Event date: | 28.07.2022 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HU FG4S E039859 | Code Expl.: | +GRANT OF SUPPLEMENTARY PROTECTION CERTIFICATE | SPC Suppl Protection Certif: | S2100010 | Filing DATE: | 20210323 | | Event date: | 15.08.2022 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG AT SPCG 997491 AT T | Code Expl.: | +GRANT OF AN SPC | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/20/1500 (MITTEILUNG) 20210108 | SPC Suppl Protection Certif: | 7/2021 | Filing DATE: | 20210303 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | Effective DATE: | 20220815 | | Event date: | 14.10.2022 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20220915 | Year of Fee Payment: | 12 | | Event date: | 15.03.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FR CP | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 21C1012 | Filing DATE: | 20210315 | Extension DATE: | 20360108 | | Event date: | 17.02.2023 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FR CT | Code Expl.: | +GRANTED SUPPLEMENTARY PROTECTION CERTIFICATE (SPC) FOR MEDICINE (EEC REGULATION OF 18 JUNE 1992) | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 21C1012 | Filing DATE: | 20210315 | Extension DATE: | 20360108 | | Event date: | 28.06.2023 | | Event description: | OPT-OUT OF THE COMPETENCE OF THE UNIFIED PATENT COURT (UPC) REGISTERED | Effective DATE: | 20230521 | | Event date: | 10.08.2023 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG LT SPCG | Code Expl.: | +GRANT OF AN SPC | Free Format Text: | PRODUCT NAME: BALOKSAVIRO MARBOKSILAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/20/1500 20210107 | SPC Suppl Protection Certif: | PA2021505,C2620436 | Filing DATE: | 20210319 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | | Event date: | 29.09.2023 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20230809 | Year of Fee Payment: | 13 | | Event date: | 15.11.2023 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG GB CTFG | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF.; REGISTERED: UK EU/1/20/1500(FOR NI) 20210108; UK FURTHER MAS ON IPSUM 20210108 | SPC Suppl Protection Certif: | SPC/GB21/036 | Filing DATE: | 20210622 | Extension DATE: | 20360107 | Effective DATE: | 20231019 | | Event date: | 17.01.2024 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG IE SPCG | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 5410/045 | Extension DATE: | 20360107 | Effective DATE: | 20231218 | | Event date: | 27.09.2024 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20240826 | Year of Fee Payment: | 14 | | Event date: | 25.07.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG LT SPCE | Code Expl.: | +FILING AN EXTENSION OF AN SPC (FOR PAEDIATRIC MEDICAMENTS) | Free Format Text: | PRODUCT NAME: BALOKSAVIRO MARBOKSILAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/20/1500 20210107 | SPC Suppl Protection Certif: | PA2021505,C2620436 | Filing DATE: | 20210319 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | Effective DATE: | 20250703 | | Event date: | 11.08.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG LT SPCZ | Code Expl.: | +GRANT OF EXTENSION OF AN SPC (FOR PAEDIATRIC MEDICAMENTS) | Free Format Text: | PRODUCT NAME: BALOKSAVIRO MARBOKSILAS ARBA FARMACINIU POZIURIU PRIIMTINA JO DRUSKA ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/20/1500 20210107 | SPC Suppl Protection Certif: | PA2021505,C2620436 | Filing DATE: | 20210319 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | | Event date: | 30.07.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG IE SPCE | Code Expl.: | +REQUEST FOR EXTENSION OF SUPPLEMENTARY PROTECTION CERTIFICATE FILED [PAEDIATRIC EXTENSION] | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 5410/045 | Effective DATE: | 20250701 | | Event date: | 14.08.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG ES SPCA | Code Expl.: | +APPLICATION FOR EXTENSION OF SUPPLEMENTARY PROTECTION CERTIFICATE FILED [PAEDIATRIC EXTENSION] | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1500; DATE OF FIRST AUTHORISATION IN EEA: 20210107 | SPC Suppl Protection Certif: | C202130015 | Extension DATE: | 20360108 | Effective DATE: | 20250717 | | Event date: | 18.08.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FR SPCY | Code Expl.: | +REQUEST FOR EXTENSION OF A SUPPLEMENTARY PROTECTION CERTIFICATE FOR MEDICATION | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 21C1012 | Filing DATE: | 20210315 | Extension DATE: | 20360108 | | Event date: | 15.09.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | NL | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 19.09.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG FR SPCJ | Code Expl.: | +PUBLICATION OF THE APPLICATION TO PROLONGATE AN SPC | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE OU UN SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 21C1012 | Filing DATE: | 20210315 | Extension DATE: | 20360108 | | Event date: | 26.09.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG HR ODRP P20181250 HR | Code Expl.: | +RENEWAL FEE FOR THE MAINTENANCE OF A PATENT | Payment DATE: | 20250903 | Year of Fee Payment: | 15 | | Event date: | 09.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | FI | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 09.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | PT | Payment DATE: | 20250826 | Year of Fee Payment: | 15 | | Event date: | 10.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | LT | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 10.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | DK | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 10.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | DE | Payment DATE: | 20250730 | Year of Fee Payment: | 15 | | Event date: | 13.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | GR | Payment DATE: | 20250822 | Year of Fee Payment: | 15 | | Event date: | 13.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | NO | Payment DATE: | 20250825 | Year of Fee Payment: | 15 | | Event date: | 14.10.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SE SPCG | Code Expl.: | +SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REG. NO/DATE: EU/1/20/1500 20210108 | SPC Suppl Protection Certif: | 2190007-1 | Expiry DATE: | 20310922 | Extension DATE: | 20360108 | | Event date: | 15.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | TR | Payment DATE: | 20250829 | Year of Fee Payment: | 15 | | Event date: | 15.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | PL | Payment DATE: | 20250826 | Year of Fee Payment: | 15 | | Event date: | 15.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | IT | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 16.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | BG | Payment DATE: | 20250826 | Year of Fee Payment: | 15 | | Event date: | 16.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | HU | Payment DATE: | 20250917 | Year of Fee Payment: | 15 | | Event date: | 16.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | BE | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 16.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | GB | Payment DATE: | 20250731 | Year of Fee Payment: | 15 | | Event date: | 01.10.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG CH U11 | Code Expl.: | +FULL RENEWAL OR MAINTENANCE FEE PAID | Free Format Text: | ST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE) | Effective DATE: | 20251001 | | Event date: | 17.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | HR | Payment DATE: | 20250903 | Year of Fee Payment: | 15 | | Event date: | 20.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | FR | Payment DATE: | 20250808 | Year of Fee Payment: | 15 | | Event date: | 20.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | AT | Payment DATE: | 20250822 | Year of Fee Payment: | 15 | | Event date: | 21.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | SE | Payment DATE: | 20250820 | Year of Fee Payment: | 15 | | Event date: | 22.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | RS | Payment DATE: | 20250828 | Year of Fee Payment: | 15 | | Event date: | 22.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | CZ | Payment DATE: | 20250828 | Year of Fee Payment: | 15 | | Event date: | 22.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | IE | Payment DATE: | 20250822 | Year of Fee Payment: | 15 | | Event date: | 17.10.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG ES SPCZ | Code Expl.: | +EXTENSION OF SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED [PAEDIATRIC EXTENSION] | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1500; DATE OF FIRST AUTHORISATION IN EEA: 20210107 | SPC Suppl Protection Certif: | C202130015 | Extension DATE: | 20360108 | Effective DATE: | 20251013 | | Event date: | 24.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | RO | Payment DATE: | 20250918 | Year of Fee Payment: | 15 | | Event date: | 27.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | SK | Payment DATE: | 20250827 | Year of Fee Payment: | 15 | | Event date: | 29.10.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG GB SPCY | Code Expl.: | REQUEST FOR EXTENSION OF SUPPLEMENTARY PROTECTION CERTIFICATE FILED [PAEDIATRIC EXTENSION] | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF.; REGISTERED: UK EU/1/20/1500(FOR NI) 20210108; UK MORE ON HISTORY TAB 20210108 | SPC Suppl Protection Certif: | SPC/GB21/036 | Filing DATE: | 20250828 | | Event date: | 31.10.2025 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | SI | Payment DATE: | 20250828 | Year of Fee Payment: | 15 | | Event date: | 15.11.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG AT SPCE 997491 AT T | Code Expl.: | +FILING FOR EXTENDING AN SPC (PAEDIATRIC MEDICAMENT) | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/20/1500 (MITTEILUNG) 20210108 | SPC Suppl Protection Certif: | 7/2021 | Filing DATE: | 20210303 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | Effective DATE: | 20251115 | | Event date: | 15.01.2026 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG AT SPCZ 997491 AT T | Code Expl.: | +GRANT OF EXTENSION FOR AN SPC (PAEDIATRIC MEDICAMENT) | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/20/1500 (MITTEILUNG) 20210108 | SPC Suppl Protection Certif: | 7/2021 | Filing DATE: | 20210303 | Expiry DATE: | 20310921 | Extension DATE: | 20360708 | Effective DATE: | 20260115 | | Event date: | 19.01.2026 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | CH | Payment DATE: | 20251001 | Year of Fee Payment: | 15 | | Event date: | 30.01.2026 | | Event description: | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | Ref Country Code: | ES | Payment DATE: | 20251001 | Year of Fee Payment: | 15 | | Event date: | 30.04.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SI SPCF 2620436 SI T1 | Code Expl.: | APPLICATION FOR SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF NATIONAL AUTHORISATION: 20210107; AUTHORITY FOR NATIONAL AUTHORISATION: EU | SPC Suppl Protection Certif: | 202140003 | Filing DATE: | 20210302 | | Event date: | 30.07.2021 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SI SPCG 2620436 SI T1 | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF NATIONAL AUTHORISATION: 20210107; AUTHORITY FOR NATIONAL AUTHORISATION: EU | SPC Suppl Protection Certif: | 202140003 | Filing DATE: | 20210302 | Expiry DATE: | 20310921 | Extension DATE: | 20360108 | | Event date: | 29.08.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SI SPCE 2620436 SI T1 | Code Expl.: | APPLICATION FOR EXTENSION OF SUPPLEMENTARY PROTECTION CERTIFICATE FILED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF NATIONAL AUTHORISATION: 20210107; AUTHORITY FOR NATIONAL AUTHORISATION: EU | SPC Suppl Protection Certif: | 202140003 | Filing DATE: | 20210302 | | Event date: | 30.10.2025 | | Event description: | REFERENCE TO A NATIONAL CODE | Event code: | REG SI SPCZ 2620436 SI T1 | Code Expl.: | SUPPLEMENTARY PROTECTION CERTIFICATE EXTENSION GRANTED | Free Format Text: | PRODUCT NAME: BALOXAVIR MARBOXIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/20/1500; DATE OF NATIONAL AUTHORISATION: 20210107; AUTHORITY FOR NATIONAL AUTHORISATION: EU | SPC Suppl Protection Certif: | 202140003 | Filing DATE: | 20210302 | Expiry DATE: | 20310921 | Extension DATE: | 20360708 | |
